"Parent Molecule ChEMBL ID";"Parent Molecule Name";"Parent Molecule Type";"Max Phase";"First Approval";"USAN Stem";"Smiles";"Mechanism of Action";"Mechanism Comment";"Selectivity Comment";"Target ChEMBL ID";"Target Name";"Action Type";"Target Type";"Target Organism";"Binding Site Name";"Binding Site Comment";"References";"Synonyms";"ATC Codes";"Level 4 ATC Codes";"Level 3 ATC Codes";"Level 2 ATC Codes";"Level 1 ATC Codes";"Parent Molecule ChEMBL ID"
"CHEMBL429910";"DAPAGLIFLOZIN";"Small molecule";"4";"2014";"'-gliflozin'";"CCOc1ccc(Cc2cc([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1";"Sodium/glucose cotransporter 2 inhibitor";"";"";"CHEMBL3884";"Sodium/glucose cotransporter 2";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=fc6ae30e-868b-4ac9-b69d-900922503998 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fc6ae30e-868b-4ac9-b69d-900922503998";"Dapagliflozin (FDA, INN)|Dapagliflozin propanediol (FDA)|Dapagliflozin Propylene Glycol (USAN)|";"A10BK01";"A10BK - Sodium-glucose co-transporter 2 (SGLT2) inhibitors";"A10B - BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS";"A10 - DRUGS USED IN DIABETES";"A - ALIMENTARY TRACT AND METABOLISM";"CHEMBL429910"
"CHEMBL1908391";"MASITINIB";"Small molecule";"3";"None";"'-tinib'";"Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1";"Fibroblast growth factor receptor 3 inhibitor";"Approved veterinary - 2012. Not recommended for approval (Negative opinion) in EU, phase 3 trials in US.";"";"CHEMBL2742";"Fibroblast growth factor receptor 3";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: Other RefID: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/veterinary/000128/WC500064717.pdf URL: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/veterinary/000128/WC500064717.pdf|Type: PubMed RefID: 19541476 URL: http://europepmc.org/abstract/MED/19541476|Type: PubMed RefID: 19789626 URL: http://europepmc.org/abstract/MED/19789626";"Masitinib (MI, INN)|";"L01XE22";"L01XE - Protein kinase inhibitors";"L01X - OTHER ANTINEOPLASTIC AGENTS";"L01 - ANTINEOPLASTIC AGENTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL1908391"
"CHEMBL595";"PIOGLITAZONE";"Small molecule";"4";"1999";"'-glitazone'";"CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1";"Peroxisome proliferator-activated receptor gamma agonist";"";"";"CHEMBL235";"Peroxisome proliferator-activated receptor gamma";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=d2ddc491-88a9-4063-9150-443b4fa4330c URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d2ddc491-88a9-4063-9150-443b4fa4330c";"Pioglitazone (BAN, INN, MI)|Pioglitazone HCl (FDA, JAN, MI, USAN, USP)|";"A10BG03";"A10BG - Thiazolidinediones";"A10B - BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS";"A10 - DRUGS USED IN DIABETES";"A - ALIMENTARY TRACT AND METABOLISM";"CHEMBL595"
"CHEMBL2105760";"BREXPIPRAZOLE";"Small molecule";"4";"2015";"'-prazole'";"O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1";"Serotonin 1a (5-HT1a) receptor partial agonist";"";"";"CHEMBL214";"Serotonin 1a (5-HT1a) receptor";"PARTIAL AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: FDA RefID: label/2015/205422s000lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205422s000lbl.pdf";"Brexpiprazole (FDA, INN, JAN, USAN)|";"N05AX16";"N05AX - Other antipsychotics";"N05A - ANTIPSYCHOTICS";"N05 - PSYCHOLEPTICS";"N - NERVOUS SYSTEM";"CHEMBL2105760"
"CHEMBL796";"METHYLPHENIDATE";"Small molecule";"4";"1955";"";"COC(=O)C(c1ccccc1)C1CCCCN1";"Norepinephrine transporter inhibitor";"";"";"CHEMBL222";"Norepinephrine transporter";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=1a88218c-5b18-4220-8f56-526de1a276cd#nlm34090-1 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1a88218c-5b18-4220-8f56-526de1a276cd#nlm34090-1|Type: PubMed RefID: 23284812 URL: http://europepmc.org/abstract/MED/23284812";"Methylphenidate HCl (FDA, JAN, MI, USP)|Methylphenidate (BAN, FDA, INN, MI, USAN)|";"N06BA04";"N06BA - Centrally acting sympathomimetics";"N06B - PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS";"N06 - PSYCHOANALEPTICS";"N - NERVOUS SYSTEM";"CHEMBL796"
"CHEMBL135";"ESTRADIOL";"Small molecule";"4";"1975";"'estr-'";"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O";"Estrogen receptor alpha agonist";"";"";"CHEMBL206";"Estrogen receptor alpha";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=0f943869-41a2-4f7e-943d-dd8c17996dd8#nlm34090-1 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0f943869-41a2-4f7e-943d-dd8c17996dd8#nlm34090-1|Type: Wikipedia RefID: Estrogen_receptor URL: http://en.wikipedia.org/wiki/Estrogen_receptor";"Estradiol (BAN, FDA, INN, JAN, MI, USP)|Estradiol Hemihydrate (FDA)|";"G03CA03 | G03CA53";"G03CA - Natural and semisynthetic estrogens, plain | G03CA - Natural and semisynthetic estrogens, plain";"G03C - ESTROGENS | G03C - ESTROGENS";"G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM | G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM";"G - GENITO URINARY SYSTEM AND SEX HORMONES | G - GENITO URINARY SYSTEM AND SEX HORMONES";"CHEMBL135"
"CHEMBL787";"MONTELUKAST";"Small molecule";"4";"1998";"'-ast'";"CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1";"Cysteinyl leukotriene receptor 1 antagonist";"";"Selective";"CHEMBL1798";"Cysteinyl leukotriene receptor 1";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=ed2caffa-a75c-1c27-ae30-2d8280eaea7d URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ed2caffa-a75c-1c27-ae30-2d8280eaea7d";"Montelukast (BAN, INN, MI)|Montelukast monosodium salt (MI)|Montelukast Sodium (FDA, JAN, USAN, USP)|";"R03DC03 | R03DC53";"R03DC - Leukotriene receptor antagonists | R03DC - Leukotriene receptor antagonists";"R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES | R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES";"R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES | R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES";"R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM";"CHEMBL787"
"CHEMBL1512580";"XALIPRODEN";"Small molecule";"3";"None";"";"FC(F)(F)c1cccc(C2=CCN(CCc3ccc4ccccc4c3)CC2)c1";"Serotonin 1a (5-HT1a) receptor agonist";"It has neurotrophic and neuroprotective activities. Although its mechanism of action is not fully understood, xaliproden appears to either mimic the effects of neurotrophins or stimulate their synthesis, thereby stimulating neuronal cell differentiation and proliferation and inhibiting neuronal cell death.";"";"CHEMBL214";"Serotonin 1a (5-HT1a) receptor";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"It binds competitively, and with high affinity (Ki = 2.0 nM) to 5-HT1a receptors";"Type: Other RefID: https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=480399 URL: https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=480399|Type: PubMed RefID: 19508400 URL: http://europepmc.org/abstract/MED/19508400|Type: PubMed RefID: 27562704 URL: http://europepmc.org/abstract/MED/27562704|Type: PubMed RefID: 8314196 URL: http://europepmc.org/abstract/MED/8314196";"Xaliproden (BAN, INN, MI, USAN)|";"N07XX03";"N07XX - Other nervous system drugs";"N07X - OTHER NERVOUS SYSTEM DRUGS";"N07 - OTHER NERVOUS SYSTEM DRUGS";"N - NERVOUS SYSTEM";"CHEMBL1512580"
"CHEMBL2103880";"CERLAPIRDINE";"Small molecule";"2";"None";"'-pirdine'";"CN(C)CCCOc1ccc2[nH]nc(S(=O)(=O)c3cccc4ccccc34)c2c1";"Serotonin 6 (5-HT6) receptor antagonist";"";"";"CHEMBL3371";"Serotonin 6 (5-HT6) receptor";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 25217486 URL: http://europepmc.org/abstract/MED/25217486";"Cerlapirdine HCl (USAN)|Cerlapirdine (INN, USAN)|";"";"";"";"";"";"CHEMBL2103880"
"CHEMBL1536";"ERGOCALCIFEROL";"Small molecule";"4";"1941";"'-calci-'";"C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)/C=C/[C@H](C)C(C)C";"Vitamin D receptor agonist";"";"";"CHEMBL1977";"Vitamin D receptor";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 16949927 URL: http://europepmc.org/abstract/MED/16949927|Type: PubMed RefID: 17218095 URL: http://europepmc.org/abstract/MED/17218095|Type: PubMed RefID: 17519354 URL: http://europepmc.org/abstract/MED/17519354";"Ergocalciferol (BAN, FDA, INN, JAN, USP)|Vitamin D2 (MI)|";"A11CC01";"A11CC - Vitamin D and analogues";"A11C - VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO";"A11 - VITAMINS";"A - ALIMENTARY TRACT AND METABOLISM";"CHEMBL1536"
"CHEMBL118";"CELECOXIB";"Small molecule";"4";"1998";"'-coxib'";"Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1";"Cyclooxygenase-2 inhibitor";"";"";"CHEMBL230";"Cyclooxygenase-2";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=90f074fa-f205-4039-822e-d09049812237 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=90f074fa-f205-4039-822e-d09049812237";"Celecoxib (BAN, FDA, INN, JAN, MI, USAN, USP)|";"L01XX33 | M01AH01";"L01XX - Other antineoplastic agents | M01AH - Coxibs";"L01X - OTHER ANTINEOPLASTIC AGENTS | M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS";"L01 - ANTINEOPLASTIC AGENTS | M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | M - MUSCULO-SKELETAL SYSTEM";"CHEMBL118"
"CHEMBL3306803";"LUMATEPERONE";"Small molecule";"3";"None";"'-perone'";"CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12";"Serotonin 2a (5-HT2a) receptor antagonist";"Atypical antipsychotic, shows partial agonism at the presynaptic D2 receptors and acts as an antagonist at postsynaptic D2 receptors (PMID: 25120104).";"";"CHEMBL224";"Serotonin 2a (5-HT2a) receptor";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: Other RefID: http://www.intracellulartherapies.com/products-technology/iti-007.html URL: http://www.intracellulartherapies.com/products-technology/iti-007.html|Type: PubMed RefID: 24559051 URL: http://europepmc.org/abstract/MED/24559051|Type: PubMed RefID: 25120104 URL: http://europepmc.org/abstract/MED/25120104";"Lumateperone tosylate (USAN)|Lumateperone (USAN)|";"";"";"";"";"";"CHEMBL3306803"
"CHEMBL52440";"DEXTROMETHORPHAN";"Small molecule";"4";"1982";"'-orphan'";"COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3";"Glutamate [NMDA] receptor subunit epsilon 1 antagonist";"";"";"CHEMBL1972";"Glutamate [NMDA] receptor subunit epsilon 1";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 2897648 URL: http://europepmc.org/abstract/MED/2897648|Type: Wikipedia RefID: Dextromethorphan URL: http://en.wikipedia.org/wiki/Dextromethorphan|Type: Wikipedia RefID: Nmda_receptor_antagonist URL: http://en.wikipedia.org/wiki/Nmda_receptor_antagonist";"Dextromethorphan Polistirex (FDA, USAN)|Dextromethorphan Hydrobromide (BAN, FDA, JAN, USP)|Deudextromethorphan (USAN)|Dextromethorphan (BAN, INN, USP)|Deudextromethorphan hydrobromide (USAN)|";"N07XX59 | R05DA09";"N07XX - Other nervous system drugs | R05DA - Opium alkaloids and derivatives";"N07X - OTHER NERVOUS SYSTEM DRUGS | R05D - COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS";"N07 - OTHER NERVOUS SYSTEM DRUGS | R05 - COUGH AND COLD PREPARATIONS";"N - NERVOUS SYSTEM | R - RESPIRATORY SYSTEM";"CHEMBL52440"
"CHEMBL3545176";"DB959";"Small molecule";"1";"None";"";"None";"Peroxisome proliferator-activated receptor delta agonist";"Ph1b study completed in 2011 (no trial ID). Compound outlicensed to T3D Therapeutics Inc in 2013.";"";"CHEMBL3979";"Peroxisome proliferator-activated receptor delta";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: Other RefID: http://www.darabio.com/media-center/press-releases?detail=134 URL: http://www.darabio.com/media-center/press-releases?detail=134|Type: Other RefID: http://www.t3dtherapeutics.com/product-portfolio/ URL: http://www.t3dtherapeutics.com/product-portfolio/";"DB-959";"";"";"";"";"";"CHEMBL3545176"
"CHEMBL1421";"DASATINIB";"Small molecule";"4";"2006";"'-tinib'";"Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1";"Platelet-derived growth factor receptor beta inhibitor";"";"";"CHEMBL1913";"Platelet-derived growth factor receptor beta";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13";"Dasatinib (FDA, INN, MI, USAN)|Dasatinib hydrate (JAN)|";"L01XE06";"L01XE - Protein kinase inhibitors";"L01X - OTHER ANTINEOPLASTIC AGENTS";"L01 - ANTINEOPLASTIC AGENTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL1421"
"CHEMBL972";"SELEGILINE";"Small molecule";"4";"1989";"'-giline'";"C#CCN(C)[C@H](C)Cc1ccccc1";"Monoamine oxidase B inhibitor";"Irreversible inhibitor";"";"CHEMBL2039";"Monoamine oxidase B";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: FDA RefID: label/2008/021479s003s004lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021479s003s004lbl.pdf";"Selegiline HCl (FDA, JAN, MI, USAN, USP)|Selegiline (BAN, FDA, INN, MI, USAN)|";"N04BD01";"N04BD - Monoamine oxidase B inhibitors";"N04B - DOPAMINERGIC AGENTS";"N04 - ANTI-PARKINSON DRUGS";"N - NERVOUS SYSTEM";"CHEMBL972"
"CHEMBL465";"DRONABINOL";"Small molecule";"4";"1985";"'-nab-'";"CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21";"Cannabinoid CB1 receptor agonist";"";"";"CHEMBL218";"Cannabinoid CB1 receptor";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=68b4168b-5782-4e68-a25a-5b4e4408dbce#nlm34090-1 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=68b4168b-5782-4e68-a25a-5b4e4408dbce#nlm34090-1|Type: PubMed RefID: 16570099 URL: http://europepmc.org/abstract/MED/16570099";"Dronabinol (FDA, INN, USAN, USP)|";"A04AD10";"A04AD - Other antiemetics";"A04A - ANTIEMETICS AND ANTINAUSEANTS";"A04 - ANTIEMETICS AND ANTINAUSEANTS";"A - ALIMENTARY TRACT AND METABOLISM";"CHEMBL465"
"CHEMBL218166";"BIFEPRUNOX";"Small molecule";"3";"None";"";"O=c1[nH]c2cccc(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)c2o1";"Dopamine D2 receptor partial agonist";"";"High affinity: D3 and D4 receptors. Low affinity: a1, 5HT2A, 5HT2C, H1 and muscarinic receptors ";"CHEMBL217";"Dopamine D2 receptor";"PARTIAL AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 18597078 URL: http://europepmc.org/abstract/MED/18597078";"Bifeprunox (INN, MI, USAN)|Bifeprunox Mesylate (USAN)|";"";"";"";"";"";"CHEMBL218166"
"CHEMBL1112";"ARIPIPRAZOLE";"Small molecule";"4";"2002";"'-prazole'";"O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1";"Dopamine D2 receptor partial agonist";"";"";"CHEMBL217";"Dopamine D2 receptor";"PARTIAL AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=c040bd1d-45b7-49f2-93ea-aed7220b30ac#nlm34090-1 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c040bd1d-45b7-49f2-93ea-aed7220b30ac#nlm34090-1";"Aripiprazole (BAN, FDA, INN, JAN, MI, USAN, USP)|";"N05AX12";"N05AX - Other antipsychotics";"N05A - ANTIPSYCHOTICS";"N05 - PSYCHOLEPTICS";"N - NERVOUS SYSTEM";"CHEMBL1112"
"CHEMBL659";"GALANTAMINE";"Small molecule";"4";"2001";"";"COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2";"Acetylcholinesterase inhibitor";"";"";"CHEMBL220";"Acetylcholinesterase";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=bbdaf2f2-14e6-45c4-b807-5b22955444b0 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bbdaf2f2-14e6-45c4-b807-5b22955444b0";"Galantamine hydrobromide (FDA, USAN)|Galantamine Hydrobromide (JAN, MI, USP)|Galantamine (BAN, INN, MI, USAN)|";"N06DA04";"N06DA - Anticholinesterases";"N06D - ANTI-DEMENTIA DRUGS";"N06 - PSYCHOANALEPTICS";"N - NERVOUS SYSTEM";"CHEMBL659"
"CHEMBL1276308";"MIFEPRISTONE";"Small molecule";"4";"2000";"'-pristone'";"CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C";"Progesterone receptor antagonist";"";"Selective";"CHEMBL208";"Progesterone receptor";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=542f3fae-8bc8-4f00-9228-e4b66c9ad6a9 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=542f3fae-8bc8-4f00-9228-e4b66c9ad6a9";"Mifepristone (BAN, FDA, INN, JAN, MI, USAN, USP)|";"G03XB51 | G03XB01";"G03XB - Progesterone receptor modulators | G03XB - Progesterone receptor modulators";"G03X - OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM | G03X - OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM";"G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM | G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM";"G - GENITO URINARY SYSTEM AND SEX HORMONES | G - GENITO URINARY SYSTEM AND SEX HORMONES";"CHEMBL1276308"
"CHEMBL894";"BUPROPION";"Small molecule";"4";"1985";"";"CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1";"Norepinephrine transporter inhibitor";"";"";"CHEMBL222";"Norepinephrine transporter";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=5cb7fd36-ae36-409b-af79-9c432e1cf5d9#nlm34090-1 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5cb7fd36-ae36-409b-af79-9c432e1cf5d9#nlm34090-1|Type: PubMed RefID: 19497387 URL: http://europepmc.org/abstract/MED/19497387";"Bupropion HCl (FDA, JAN, MI, USAN, USP)|Bupropion (BAN, INN, MI)|Bupropion Hydrobromide (FDA, MI, USAN, USP)|";"N06AX12";"N06AX - Other antidepressants";"N06A - ANTIDEPRESSANTS";"N06 - PSYCHOANALEPTICS";"N - NERVOUS SYSTEM";"CHEMBL894"
"CHEMBL121";"ROSIGLITAZONE";"Small molecule";"4";"1999";"'-glitazone'";"CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1";"Peroxisome proliferator-activated receptor gamma agonist";"";"Selective";"CHEMBL235";"Peroxisome proliferator-activated receptor gamma";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=28c31e58-0b27-43e2-bae0-9bbb21420e9f URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=28c31e58-0b27-43e2-bae0-9bbb21420e9f";"Rosiglitazone (BAN, INN, MI)|Rosiglitazone maleate (FDA, JAN, MI, USAN)|";"A10BG02";"A10BG - Thiazolidinediones";"A10B - BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS";"A10 - DRUGS USED IN DIABETES";"A - ALIMENTARY TRACT AND METABOLISM";"CHEMBL121"
"CHEMBL98";"VORINOSTAT";"Small molecule";"4";"2006";"'-stat'";"O=C(CCCCCCC(=O)Nc1ccccc1)NO";"Histone deacetylase 2 inhibitor";"";"";"CHEMBL1937";"Histone deacetylase 2";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=cd86ee78-2781-468b-930c-3c4677bcc092#section-13 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd86ee78-2781-468b-930c-3c4677bcc092#section-13";"Vorinostat (FDA, INN, JAN, MI, USAN)|";"L01XX38";"L01XX - Other antineoplastic agents";"L01X - OTHER ANTINEOPLASTIC AGENTS";"L01 - ANTINEOPLASTIC AGENTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL98"
"CHEMBL3545176";"DB959";"Small molecule";"1";"None";"";"None";"Peroxisome proliferator-activated receptor gamma agonist";"Ph1b study completed in 2011 (no trial ID). Compound outlicensed to T3D Therapeutics Inc in 2013.";"";"CHEMBL235";"Peroxisome proliferator-activated receptor gamma";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: Other RefID: http://www.darabio.com/media-center/press-releases?detail=134 URL: http://www.darabio.com/media-center/press-releases?detail=134|Type: Other RefID: http://www.t3dtherapeutics.com/product-portfolio/ URL: http://www.t3dtherapeutics.com/product-portfolio/";"DB-959";"";"";"";"";"";"CHEMBL3545176"
"CHEMBL1421";"DASATINIB";"Small molecule";"4";"2006";"'-tinib'";"Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1";"Tyrosine-protein kinase ABL inhibitor";"";"";"CHEMBL1862";"Tyrosine-protein kinase ABL";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13";"Dasatinib (FDA, INN, MI, USAN)|Dasatinib hydrate (JAN)|";"L01XE06";"L01XE - Protein kinase inhibitors";"L01X - OTHER ANTINEOPLASTIC AGENTS";"L01 - ANTINEOPLASTIC AGENTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL1421"
"CHEMBL887";"RASAGILINE";"Small molecule";"4";"2006";"'-giline'";"C#CCN[C@@H]1CCc2ccccc21";"Monoamine oxidase B inhibitor";"Irreversible inhibitor";"";"CHEMBL2039";"Monoamine oxidase B";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: FDA RefID: label/2009/021641s002s003s004s005s007s008s010lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021641s002s003s004s005s007s008s010lbl.pdf";"Rasagiline mesylate (FDA, USAN)|Rasagiline (INN, MI, USAN)|";"N04BD02";"N04BD - Monoamine oxidase B inhibitors";"N04B - DOPAMINERGIC AGENTS";"N04 - ANTI-PARKINSON DRUGS";"N - NERVOUS SYSTEM";"CHEMBL887"
"CHEMBL1286";"LEVETIRACETAM";"Small molecule";"4";"1999";"'-racetam'";"CC[C@@H](C(N)=O)N1CCCC1=O";"Synaptic vesicle glycoprotein 2A modulator";"";"";"CHEMBL1998";"Synaptic vesicle glycoprotein 2A";"MODULATOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=90b553fe-4e94-4cce-b5df-ea3e6487930d#nlm34090-1 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=90b553fe-4e94-4cce-b5df-ea3e6487930d#nlm34090-1";"Levetiracetam (BAN, FDA, INN, JAN, MI, USAN, USP)|";"N03AX14";"N03AX - Other antiepileptics";"N03A - ANTIEPILEPTICS";"N03 - ANTIEPILEPTICS";"N - NERVOUS SYSTEM";"CHEMBL1286"
"CHEMBL2105760";"BREXPIPRAZOLE";"Small molecule";"4";"2015";"'-prazole'";"O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1";"Dopamine D2 receptor partial agonist";"";"";"CHEMBL217";"Dopamine D2 receptor";"PARTIAL AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: FDA RefID: label/2015/205422s000lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205422s000lbl.pdf";"Brexpiprazole (FDA, INN, JAN, USAN)|";"N05AX16";"N05AX - Other antipsychotics";"N05A - ANTIPSYCHOTICS";"N05 - PSYCHOLEPTICS";"N - NERVOUS SYSTEM";"CHEMBL2105760"
"CHEMBL796";"METHYLPHENIDATE";"Small molecule";"4";"1955";"";"COC(=O)C(c1ccccc1)C1CCCCN1";"Dopamine transporter inhibitor";"";"";"CHEMBL238";"Dopamine transporter";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=1a88218c-5b18-4220-8f56-526de1a276cd#nlm34090-1 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1a88218c-5b18-4220-8f56-526de1a276cd#nlm34090-1|Type: PubMed RefID: 23284812 URL: http://europepmc.org/abstract/MED/23284812";"Methylphenidate HCl (FDA, JAN, MI, USP)|Methylphenidate (BAN, FDA, INN, MI, USAN)|";"N06BA04";"N06BA - Centrally acting sympathomimetics";"N06B - PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS";"N06 - PSYCHOANALEPTICS";"N - NERVOUS SYSTEM";"CHEMBL796"
"CHEMBL52440";"DEXTROMETHORPHAN";"Small molecule";"4";"1982";"'-orphan'";"COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3";"Sigma opioid receptor agonist";"";"";"CHEMBL287";"Sigma opioid receptor";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 2897648 URL: http://europepmc.org/abstract/MED/2897648|Type: Wikipedia RefID: Dextromethorphan URL: http://en.wikipedia.org/wiki/Dextromethorphan|Type: Wikipedia RefID: Nmda_receptor_antagonist URL: http://en.wikipedia.org/wiki/Nmda_receptor_antagonist";"Dextromethorphan Polistirex (FDA, USAN)|Dextromethorphan Hydrobromide (BAN, FDA, JAN, USP)|Deudextromethorphan (USAN)|Dextromethorphan (BAN, INN, USP)|Deudextromethorphan hydrobromide (USAN)|";"N07XX59 | R05DA09";"N07XX - Other nervous system drugs | R05DA - Opium alkaloids and derivatives";"N07X - OTHER NERVOUS SYSTEM DRUGS | R05D - COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS";"N07 - OTHER NERVOUS SYSTEM DRUGS | R05 - COUGH AND COLD PREPARATIONS";"N - NERVOUS SYSTEM | R - RESPIRATORY SYSTEM";"CHEMBL52440"
"CHEMBL1433";"DOXYCYCLINE";"Small molecule";"4";"1967";"'-cycline'";"C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21";"Matrix metalloproteinase 7 inhibitor";"It is an antibiotic, however, its primary action, due to the concentration reached in the human body is via metalloproteinases inhibition, which is beneficial in many pathological conditions in which MMP-mediated proteolysis of the extracellular matrix (ECM) contributes to the pathogenesis, such as heart remodeling, tumor invasion, and inflammation";"";"CHEMBL4073";"Matrix metalloproteinase 7";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=3105a84b-655e-4940-9d11-4209cdb05d6b URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3105a84b-655e-4940-9d11-4209cdb05d6b|Type: PubMed RefID: 17199549 URL: http://europepmc.org/abstract/MED/17199549|Type: PubMed RefID: 20370419 URL: http://europepmc.org/abstract/MED/20370419|Type: PubMed RefID: 20592239 URL: http://europepmc.org/abstract/MED/20592239";"Doxycycline Calcium (FDA, USP)|Doxycycline (BAN, FDA, INN, USAN, USP, BAN, USAN, USP)|Doxycycline anhydrous (MI)|Doxycycline HCl (JAN)|Doxycycline Fosfatex (BAN, USAN)|Doxycycline hyclate (FDA, USP)|Doxycycline hydrochloride hydrate (JAN)|";"A01AB22 | J01AA02";"A01AB - Antiinfectives and antiseptics for local oral treatment | J01AA - Tetracyclines";"A01A - STOMATOLOGICAL PREPARATIONS | J01A - TETRACYCLINES";"A01 - STOMATOLOGICAL PREPARATIONS | J01 - ANTIBACTERIALS FOR SYSTEMIC USE";"A - ALIMENTARY TRACT AND METABOLISM | J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL1433"
"CHEMBL502";"DONEPEZIL";"Small molecule";"4";"1996";"'-pezil'";"COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2";"Acetylcholinesterase inhibitor";"";"";"CHEMBL220";"Acetylcholinesterase";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=2b1b7b5f-2f20-418c-b1ac-794c2ef1ce5e URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2b1b7b5f-2f20-418c-b1ac-794c2ef1ce5e";"Donepezil HCl (FDA, JAN, MI, USAN)|Donepezil (BAN, INN, MI)|";"N06DA02";"N06DA - Anticholinesterases";"N06D - ANTI-DEMENTIA DRUGS";"N06 - PSYCHOANALEPTICS";"N - NERVOUS SYSTEM";"CHEMBL502"
"CHEMBL1433";"DOXYCYCLINE";"Small molecule";"4";"1967";"'-cycline'";"C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21";"Matrix metalloproteinase 13 inhibitor";"It is an antibiotic, however, its primary action, due to the concentration reached in the human body is via metalloproteinases inhibition, which is beneficial in many pathological conditions in which MMP-mediated proteolysis of the extracellular matrix (ECM) contributes to the pathogenesis, such as heart remodeling, tumor invasion, and inflammation";"";"CHEMBL280";"Matrix metalloproteinase 13";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=3105a84b-655e-4940-9d11-4209cdb05d6b URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3105a84b-655e-4940-9d11-4209cdb05d6b|Type: PubMed RefID: 17199549 URL: http://europepmc.org/abstract/MED/17199549|Type: PubMed RefID: 20370419 URL: http://europepmc.org/abstract/MED/20370419|Type: PubMed RefID: 20592239 URL: http://europepmc.org/abstract/MED/20592239";"Doxycycline Calcium (FDA, USP)|Doxycycline (BAN, FDA, INN, USAN, USP, BAN, USAN, USP)|Doxycycline anhydrous (MI)|Doxycycline HCl (JAN)|Doxycycline Fosfatex (BAN, USAN)|Doxycycline hyclate (FDA, USP)|Doxycycline hydrochloride hydrate (JAN)|";"A01AB22 | J01AA02";"A01AB - Antiinfectives and antiseptics for local oral treatment | J01AA - Tetracyclines";"A01A - STOMATOLOGICAL PREPARATIONS | J01A - TETRACYCLINES";"A01 - STOMATOLOGICAL PREPARATIONS | J01 - ANTIBACTERIALS FOR SYSTEMIC USE";"A - ALIMENTARY TRACT AND METABOLISM | J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL1433"
"CHEMBL3544952";"RG3487";"Small molecule";"2";"None";"";"None";"Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist";"";"";"CHEMBL2492";"Neuronal acetylcholine receptor protein alpha-7 subunit";"PARTIAL AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 20959364 URL: http://europepmc.org/abstract/MED/20959364|Type: PubMed RefID: 21919481 URL: http://europepmc.org/abstract/MED/21919481|Type: PubMed RefID: 22408449 URL: http://europepmc.org/abstract/MED/22408449";"RG-3487";"";"";"";"";"";"CHEMBL3544952"
"CHEMBL641";"ATOMOXETINE";"Small molecule";"4";"2002";"'-oxetine'";"CNCC[C@@H](Oc1ccccc1C)c1ccccc1";"Norepinephrine transporter inhibitor";"reuptake inhibitor";"";"CHEMBL222";"Norepinephrine transporter";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: FDA RefID: label/2015/021411s046lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021411s046lbl.pdf";"Atomoxetine HCl (FDA, JAN, MI, USAN, USP)|Tomoxetine (INN)|Atomoxetine (BAN, INN, MI)|";"N06BA09";"N06BA - Centrally acting sympathomimetics";"N06B - PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS";"N06 - PSYCHOANALEPTICS";"N - NERVOUS SYSTEM";"CHEMBL641"
"CHEMBL1200826";"LITHIUM CARBONATE";"Small molecule";"4";"1970";"";"O=C([O-])[O-].[Li+].[Li+]";"Inositol-1(or 4)-monophosphatase 1 inhibitor";"";"";"CHEMBL1786";"Inositol-1(or 4)-monophosphatase 1";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: FDA RefID: label/2011/018027s056lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/018027s056lbl.pdf|Type: PubMed RefID: 22707923 URL: http://europepmc.org/abstract/MED/22707923|Type: Wikipedia RefID: Lithium_(medication) URL: http://en.wikipedia.org/wiki/Lithium_(medication)";"Lithium Carbonate (FDA, JAN, MI, USAN, USP)|";"N05AN01";"N05AN - Lithium";"N05A - ANTIPSYCHOTICS";"N05 - PSYCHOLEPTICS";"N - NERVOUS SYSTEM";"CHEMBL1200826"
"CHEMBL255863";"NILOTINIB";"Small molecule";"4";"2007";"'-tinib'";"Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1";"Tyrosine-protein kinase ABL inhibitor";"";"";"CHEMBL1862";"Tyrosine-protein kinase ABL";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=6093952a-5248-45cb-ad17-33716a411146#section-13 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6093952a-5248-45cb-ad17-33716a411146#section-13";"Nilotinib (INN, MI, USAN)|Nilotinib hydrochloride (FDA)|Nilotinib hydrochloride hydrate (JAN)|Nilotinib Hydrochloride Monohydrate (FDA, MI)|";"L01XE08";"L01XE - Protein kinase inhibitors";"L01X - OTHER ANTINEOPLASTIC AGENTS";"L01 - ANTINEOPLASTIC AGENTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL255863"
"CHEMBL621";"TRAZODONE";"Small molecule";"4";"1981";"";"O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12";"Serotonin 2c (5-HT2c) receptor antagonist";"";"";"CHEMBL225";"Serotonin 2c (5-HT2c) receptor";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: FDA RefID: label/2013/071258Orig1s040, 071196Orig1s063lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/071258Orig1s040, 071196Orig1s063lbl.pdf";"Trazodone HCl (FDA, JAN, MI, USAN, USP)|Trazodone (BAN, INN, MI)|";"N06AX05";"N06AX - Other antidepressants";"N06A - ANTIDEPRESSANTS";"N06 - PSYCHOANALEPTICS";"N - NERVOUS SYSTEM";"CHEMBL621"
"CHEMBL717";"MEDROXYPROGESTERONE ACETATE";"Small molecule";"4";"1959";"'-gest-; -ster-'";"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"Progesterone receptor agonist";"";"";"CHEMBL208";"Progesterone receptor";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=199cf13e-0859-4a73-9b45-e700d0cd1049#nlm34090-1 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=199cf13e-0859-4a73-9b45-e700d0cd1049#nlm34090-1";"Medroxyprogesterone (BAN, INN)|Medroxyprogesterone 17-acetate (MI)|Medroxyprogesterone acetate (FDA, JAN, USP)|";"L02AB02 | G03AC06 | G03DA02";"L02AB - Progestogens | G03AC - Progestogens | G03DA - Pregnen (4) derivatives";"L02A - HORMONES AND RELATED AGENTS | G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE | G03D - PROGESTOGENS";"L02 - ENDOCRINE THERAPY | G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM | G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | G - GENITO URINARY SYSTEM AND SEX HORMONES | G - GENITO URINARY SYSTEM AND SEX HORMONES";"CHEMBL717"
"CHEMBL2103849";"UDENAFIL";"Small molecule";"3";"None";"'-afil'";"CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc2c(CCC)nn(C)c2c(=O)[nH]1";"Phosphodiesterase 5A inhibitor";"";"";"CHEMBL1827";"Phosphodiesterase 5A";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 20412426 URL: http://europepmc.org/abstract/MED/20412426";"Udenafil (INN, MI, USAN)|";"G04BE11";"G04BE - Drugs used in erectile dysfunction";"G04B - UROLOGICALS";"G04 - UROLOGICALS";"G - GENITO URINARY SYSTEM AND SEX HORMONES";"CHEMBL2103849"
"CHEMBL894";"BUPROPION";"Small molecule";"4";"1985";"";"CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1";"Dopamine transporter inhibitor";"";"";"CHEMBL238";"Dopamine transporter";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=5cb7fd36-ae36-409b-af79-9c432e1cf5d9#nlm34090-1 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5cb7fd36-ae36-409b-af79-9c432e1cf5d9#nlm34090-1|Type: PubMed RefID: 19497387 URL: http://europepmc.org/abstract/MED/19497387";"Bupropion HCl (FDA, JAN, MI, USAN, USP)|Bupropion (BAN, INN, MI)|Bupropion Hydrobromide (FDA, MI, USAN, USP)|";"N06AX12";"N06AX - Other antidepressants";"N06A - ANTIDEPRESSANTS";"N06 - PSYCHOANALEPTICS";"N - NERVOUS SYSTEM";"CHEMBL894"
"CHEMBL122";"ROFECOXIB";"Small molecule";"4";"1999";"'-coxib'";"CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1";"Cyclooxygenase-2 inhibitor";"";"";"CHEMBL230";"Cyclooxygenase-2";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: FDA RefID: label/2004/021052s026_021042s019lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/021052s026_021042s019lbl.pdf";"Rofecoxib (BAN, FDA, INN, JAN, MI, USAN)|";"M01AH02";"M01AH - Coxibs";"M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS";"M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS";"M - MUSCULO-SKELETAL SYSTEM";"CHEMBL122"
"CHEMBL476323";"MK-0249";"Small molecule";"2";"None";"";"Cc1nc2cccc(C(F)(F)F)c2c(=O)n1-c1ccc(OCCCN2CCCC2)cc1";"Histamine H3 receptor inverse agonist";"";"";"CHEMBL264";"Histamine H3 receptor";"INVERSE AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 20981000 URL: http://europepmc.org/abstract/MED/20981000|Type: PubMed RefID: 24263088 URL: http://europepmc.org/abstract/MED/24263088";"MK-0249";"";"";"";"";"";"CHEMBL476323"
"CHEMBL3545231";"ABT-126";"Small molecule";"2";"None";"";"c1ccc(-c2nnc(O[C@@H]3C4CC5C[C@H]3CN(C5)C4)s2)cc1";"Neuronal acetylcholine receptor protein alpha-7 subunit agonist";"Alpha-7 nicotinic receptor: consists entirely of a7 subunits (pentamere) CNS-type.";"";"CHEMBL2492";"Neuronal acetylcholine receptor protein alpha-7 subunit";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DOI RefID: 10.1016/j.trci.2015.06.001 URL: http://www.sciencedirect.com/science/article/pii/S2352873715000104|Type: PubMed RefID: 26044974 URL: http://europepmc.org/abstract/MED/26044974";"ABT-126";"";"";"";"";"";"CHEMBL3545231"
"CHEMBL109";"VALPROIC ACID";"Small molecule";"4";"1978";"";"CCCC(CCC)C(=O)O";"Succinate semialdehyde dehydrogenase inhibitor";"";"";"CHEMBL1911";"Succinate semialdehyde dehydrogenase";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 10812195 URL: http://europepmc.org/abstract/MED/10812195";"Sodium Valproate (JAN)|Valproate Sodium (FDA, USAN, USP)|Valproic acid sodium salt (1:1) (MI)|Valproic acid (BAN, FDA, INN, MI, USAN, USP)|Divalproex Sodium (FDA, USAN, USP)|Semisodium Valproate (BAN)|Valproate Semisodium (INN)|Valproic acid sodium salt (2:1) (MI)|";"N03AG01";"N03AG - Fatty acid derivatives";"N03A - ANTIEPILEPTICS";"N03 - ANTIEPILEPTICS";"N - NERVOUS SYSTEM";"CHEMBL109"
"CHEMBL98";"VORINOSTAT";"Small molecule";"4";"2006";"'-stat'";"O=C(CCCCCCC(=O)Nc1ccccc1)NO";"Histone deacetylase 6 inhibitor";"";"";"CHEMBL1865";"Histone deacetylase 6";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=cd86ee78-2781-468b-930c-3c4677bcc092#section-13 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd86ee78-2781-468b-930c-3c4677bcc092#section-13";"Vorinostat (FDA, INN, JAN, MI, USAN)|";"L01XX38";"L01XX - Other antineoplastic agents";"L01X - OTHER ANTINEOPLASTIC AGENTS";"L01 - ANTINEOPLASTIC AGENTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL98"
"CHEMBL1433";"DOXYCYCLINE";"Small molecule";"4";"1967";"'-cycline'";"C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21";"Matrix metalloproteinase 8 inhibitor";"It is an antibiotic, however, its primary action, due to the concentration reached in the human body is via metalloproteinases inhibition, which is beneficial in many pathological conditions in which MMP-mediated proteolysis of the extracellular matrix (ECM) contributes to the pathogenesis, such as heart remodeling, tumor invasion, and inflammation";"";"CHEMBL4588";"Matrix metalloproteinase 8";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=3105a84b-655e-4940-9d11-4209cdb05d6b URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3105a84b-655e-4940-9d11-4209cdb05d6b|Type: PubMed RefID: 17199549 URL: http://europepmc.org/abstract/MED/17199549|Type: PubMed RefID: 20370419 URL: http://europepmc.org/abstract/MED/20370419|Type: PubMed RefID: 20592239 URL: http://europepmc.org/abstract/MED/20592239";"Doxycycline Calcium (FDA, USP)|Doxycycline (BAN, FDA, INN, USAN, USP, BAN, USAN, USP)|Doxycycline anhydrous (MI)|Doxycycline HCl (JAN)|Doxycycline Fosfatex (BAN, USAN)|Doxycycline hyclate (FDA, USP)|Doxycycline hydrochloride hydrate (JAN)|";"A01AB22 | J01AA02";"A01AB - Antiinfectives and antiseptics for local oral treatment | J01AA - Tetracyclines";"A01A - STOMATOLOGICAL PREPARATIONS | J01A - TETRACYCLINES";"A01 - STOMATOLOGICAL PREPARATIONS | J01 - ANTIBACTERIALS FOR SYSTEMIC USE";"A - ALIMENTARY TRACT AND METABOLISM | J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL1433"
"CHEMBL1112";"ARIPIPRAZOLE";"Small molecule";"4";"2002";"'-prazole'";"O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1";"Serotonin 1a (5-HT1a) receptor partial agonist";"";"";"CHEMBL214";"Serotonin 1a (5-HT1a) receptor";"PARTIAL AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=c040bd1d-45b7-49f2-93ea-aed7220b30ac#nlm34090-1 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c040bd1d-45b7-49f2-93ea-aed7220b30ac#nlm34090-1";"Aripiprazole (BAN, FDA, INN, JAN, MI, USAN, USP)|";"N05AX12";"N05AX - Other antipsychotics";"N05A - ANTIPSYCHOTICS";"N05 - PSYCHOLEPTICS";"N - NERVOUS SYSTEM";"CHEMBL1112"
"CHEMBL198877";"AUS-131";"Small molecule";"2";"None";"";"Oc1ccc([C@H]2COc3cc(O)ccc3C2)cc1";"Estrogen receptor beta agonist";"";"";"CHEMBL242";"Estrogen receptor beta";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: Other RefID: http://www.ausiopharma.com/TechPages/TechOverview.html URL: http://www.ausiopharma.com/TechPages/TechOverview.html";"AUS-131";"";"";"";"";"";"CHEMBL198877"
"CHEMBL1421";"DASATINIB";"Small molecule";"4";"2006";"'-tinib'";"Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1";"Stem cell growth factor receptor inhibitor";"";"";"CHEMBL1936";"Stem cell growth factor receptor";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13";"Dasatinib (FDA, INN, MI, USAN)|Dasatinib hydrate (JAN)|";"L01XE06";"L01XE - Protein kinase inhibitors";"L01X - OTHER ANTINEOPLASTIC AGENTS";"L01 - ANTINEOPLASTIC AGENTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL1421"
"CHEMBL325424";"ALEPLASININ";"Small molecule";"1";"None";"'-plasinin'";"Cc1cccc(-c2ccc3c(c2)c(C(=O)C(=O)O)cn3Cc2ccc(C(C)(C)C)cc2)c1";"Plasminogen activator inhibitor-1 inhibitor";"";"";"CHEMBL3475";"Plasminogen activator inhibitor-1";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 22110351 URL: http://europepmc.org/abstract/MED/22110351";"Aleplasinin (INN, USAN)|";"";"";"";"";"";"CHEMBL325424"
"CHEMBL2151437";"AZD0328";"Small molecule";"2";"None";"";"c1cnc2c(c1)C[C@@]1(CN3CCC1CC3)O2";"Neuronal acetylcholine receptor protein alpha-7 subunit agonist";"Compound is listed in AstaZeneca's clinical and/or preclinical compound bank and available for research projects (http://openinnovation.astrazeneca.com/what-we-offer/compound/azd0328-2/).";"";"CHEMBL2492";"Neuronal acetylcholine receptor protein alpha-7 subunit";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 19615981 URL: http://europepmc.org/abstract/MED/19615981|Type: PubMed RefID: 21919481 URL: http://europepmc.org/abstract/MED/21919481";"AZD-0328";"";"";"";"";"";"CHEMBL2151437"
"CHEMBL621";"TRAZODONE";"Small molecule";"4";"1981";"";"O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12";"Serotonin transporter inhibitor";"";"";"CHEMBL228";"Serotonin transporter";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: FDA RefID: label/2013/071258Orig1s040, 071196Orig1s063lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/071258Orig1s040, 071196Orig1s063lbl.pdf";"Trazodone HCl (FDA, JAN, MI, USAN, USP)|Trazodone (BAN, INN, MI)|";"N06AX05";"N06AX - Other antidepressants";"N06A - ANTIDEPRESSANTS";"N06 - PSYCHOANALEPTICS";"N - NERVOUS SYSTEM";"CHEMBL621"
"CHEMBL637";"VENLAFAXINE";"Small molecule";"4";"1993";"'-faxine'";"COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1";"Norepinephrine transporter inhibitor";"";"";"CHEMBL222";"Norepinephrine transporter";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=f2f03495-12b6-457a-901f-958b9c844bfd#nlm34090-1 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f2f03495-12b6-457a-901f-958b9c844bfd#nlm34090-1";"Venlafaxine (BAN, INN, MI)|Venlafaxine HCl (FDA, JAN, MI, USAN, USP)|";"N06AX16";"N06AX - Other antidepressants";"N06A - ANTIDEPRESSANTS";"N06 - PSYCHOANALEPTICS";"N - NERVOUS SYSTEM";"CHEMBL637"
"CHEMBL98";"VORINOSTAT";"Small molecule";"4";"2006";"'-stat'";"O=C(CCCCCCC(=O)Nc1ccccc1)NO";"Histone deacetylase 3 inhibitor";"";"";"CHEMBL1829";"Histone deacetylase 3";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=cd86ee78-2781-468b-930c-3c4677bcc092#section-13 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd86ee78-2781-468b-930c-3c4677bcc092#section-13";"Vorinostat (FDA, INN, JAN, MI, USAN)|";"L01XX38";"L01XX - Other antineoplastic agents";"L01X - OTHER ANTINEOPLASTIC AGENTS";"L01 - ANTINEOPLASTIC AGENTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL98"
"CHEMBL356388";"ETAZOLATE";"Small molecule";"2";"None";"";"CCOC(=O)c1cnc2c(cnn2CC)c1NN=C(C)C";"GABA receptor beta-3 subunit positive allosteric modulator";"";"";"CHEMBL1847";"GABA receptor beta-3 subunit";"POSITIVE ALLOSTERIC MODULATOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: Other RefID: http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7336 URL: http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7336|Type: Wikipedia RefID: Etazolate URL: https://en.wikipedia.org/wiki/Etazolate";"Etazolate HCl (USAN)|Etazolate (INN)|";"";"";"";"";"";"CHEMBL356388"
"CHEMBL1908391";"MASITINIB";"Small molecule";"3";"None";"'-tinib'";"Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1";"Stem cell growth factor receptor inhibitor";"Approved veterinary - 2012. Not recommended for approval (Negative opinion) in EU, phase 3 trials in US.";"";"CHEMBL1936";"Stem cell growth factor receptor";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: Other RefID: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/veterinary/000128/WC500064717.pdf URL: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/veterinary/000128/WC500064717.pdf|Type: PubMed RefID: 19541476 URL: http://europepmc.org/abstract/MED/19541476|Type: PubMed RefID: 19789626 URL: http://europepmc.org/abstract/MED/19789626";"Masitinib (MI, INN)|";"L01XE22";"L01XE - Protein kinase inhibitors";"L01X - OTHER ANTINEOPLASTIC AGENTS";"L01 - ANTINEOPLASTIC AGENTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL1908391"
"CHEMBL1064";"SIMVASTATIN";"Small molecule";"4";"1991";"'-stat-'";"CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21";"HMG-CoA reductase inhibitor";"";"";"CHEMBL402";"HMG-CoA reductase";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=e9e50cdb-4cef-4d03-9fb6-973d0c2bf293 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e9e50cdb-4cef-4d03-9fb6-973d0c2bf293";"Simvastatin (BAN, FDA, INN, JAN, MI, USAN, USP)|";"C10AA01";"C10AA - HMG CoA reductase inhibitors";"C10A - LIPID MODIFYING AGENTS, PLAIN";"C10 - LIPID MODIFYING AGENTS";"C - CARDIOVASCULAR SYSTEM";"CHEMBL1064"
"CHEMBL3306803";"LUMATEPERONE";"Small molecule";"3";"None";"'-perone'";"CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12";"Dopamine D2 receptor partial agonist";"Atypical antipsychotic, shows partial agonism at the presynaptic D2 receptors and acts as an antagonist at postsynaptic D2 receptors (PMID: 25120104).";"";"CHEMBL217";"Dopamine D2 receptor";"PARTIAL AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: Other RefID: http://www.intracellulartherapies.com/products-technology/iti-007.html URL: http://www.intracellulartherapies.com/products-technology/iti-007.html|Type: PubMed RefID: 24559051 URL: http://europepmc.org/abstract/MED/24559051|Type: PubMed RefID: 25120104 URL: http://europepmc.org/abstract/MED/25120104";"Lumateperone tosylate (USAN)|Lumateperone (USAN)|";"";"";"";"";"";"CHEMBL3306803"
"CHEMBL2151572";"ENCENICLINE";"Small molecule";"3";"None";"'-nicline'";"O=C(N[C@H]1CN2CCC1CC2)c1cc2cccc(Cl)c2s1";"Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist";"Alpha-7 nicotinic receptor: consists entirely of a7 subunits (pentamere) CNS-type.";"";"CHEMBL2492";"Neuronal acetylcholine receptor protein alpha-7 subunit";"PARTIAL AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 22085888 URL: http://europepmc.org/abstract/MED/22085888|Type: PubMed RefID: 26044974 URL: http://europepmc.org/abstract/MED/26044974";"Encenicline Hydrochloride (USAN)|Encenicline (INN, USAN)|";"";"";"";"";"";"CHEMBL2151572"
"CHEMBL3545157";"TIDEGLUSIB";"Small molecule";"2";"None";"";"O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1";"Glycogen synthase kinase-3 beta inhibitor";"";"";"CHEMBL262";"Glycogen synthase kinase-3 beta";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 22102280 URL: http://europepmc.org/abstract/MED/22102280";"Tideglusib (INN)|";"";"";"";"";"";"CHEMBL3545157"
"CHEMBL3545344";"PF-05212377";"Small molecule";"2";"None";"";"None";"Serotonin 6 (5-HT6) receptor antagonist";"";"";"CHEMBL3371";"Serotonin 6 (5-HT6) receptor";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: Other RefID: http://www.pfizer.com/research/science_and_technology/product_pipeline URL: http://www.pfizer.com/research/science_and_technology/product_pipeline";"PF-05212377";"";"";"";"";"";"CHEMBL3545344"
"CHEMBL569713";"SCOPOLAMINE";"Small molecule";"4";"1979";"";"CN1[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@@H]1[C@H]1O[C@@H]21";"Muscarinic acetylcholine receptor M1 antagonist";"antiemetic";"";"CHEMBL216";"Muscarinic acetylcholine receptor M1";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: ISBN RefID: 9780702034718 PP. 153, 162 URL: http://www.isbnsearch.org/isbn/9780702034718|Type: PubMed RefID: 23615033 URL: http://europepmc.org/abstract/MED/23615033";"Hyoscine (BAN)|Scopolamine Hydrobromide (JAN, MI, USP)|Scopolamine hydrobromide hydrate (JAN)|Scopolamine hydrobromide trihydrate (MI)|Scopolamine (FDA, MI)|";"A04AD51 | S01FA02 | A04AD01 | N05CM05";"A04AD - Other antiemetics | S01FA - Anticholinergics | A04AD - Other antiemetics | N05CM - Other hypnotics and sedatives";"A04A - ANTIEMETICS AND ANTINAUSEANTS | S01F - MYDRIATICS AND CYCLOPLEGICS | A04A - ANTIEMETICS AND ANTINAUSEANTS | N05C - HYPNOTICS AND SEDATIVES";"A04 - ANTIEMETICS AND ANTINAUSEANTS | S01 - OPHTHALMOLOGICALS | A04 - ANTIEMETICS AND ANTINAUSEANTS | N05 - PSYCHOLEPTICS";"A - ALIMENTARY TRACT AND METABOLISM | S - SENSORY ORGANS | A - ALIMENTARY TRACT AND METABOLISM | N - NERVOUS SYSTEM";"CHEMBL569713"
"CHEMBL3545232";"AQW051";"Small molecule";"2";"None";"";"Cc1ccc(-c2ccc(OC3CN4CCC3CC4)cn2)cc1";"Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist";"Alpha-7 nicotinic receptor: consists entirely of a7 subunits (pentamere) CNS-type.";"";"CHEMBL2492";"Neuronal acetylcholine receptor protein alpha-7 subunit";"PARTIAL AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 25172125 URL: http://europepmc.org/abstract/MED/25172125|Type: PubMed RefID: 25363835 URL: http://europepmc.org/abstract/MED/25363835";"AQW051";"";"";"";"";"";"CHEMBL3545232"
"CHEMBL98";"VORINOSTAT";"Small molecule";"4";"2006";"'-stat'";"O=C(CCCCCCC(=O)Nc1ccccc1)NO";"Histone deacetylase 1 inhibitor";"";"";"CHEMBL325";"Histone deacetylase 1";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=cd86ee78-2781-468b-930c-3c4677bcc092#section-13 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd86ee78-2781-468b-930c-3c4677bcc092#section-13";"Vorinostat (FDA, INN, JAN, MI, USAN)|";"L01XX38";"L01XX - Other antineoplastic agents";"L01X - OTHER ANTINEOPLASTIC AGENTS";"L01 - ANTINEOPLASTIC AGENTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL98"
"CHEMBL3545166";"DRINABANT";"Small molecule";"3";"None";"'-nab-'";"CS(=O)(=O)N(c1cc(F)cc(F)c1)C1CN(C(c2ccc(Cl)cc2)c2ccc(Cl)cc2)C1";"Cannabinoid CB1 receptor antagonist";"Discontinued possibly due to psychiatric side effects as seen with withdrawn CNR1 antagonist rimonabant.";"";"CHEMBL218";"Cannabinoid CB1 receptor";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 18801827 URL: http://europepmc.org/abstract/MED/18801827|Type: PubMed RefID: 21170298 URL: http://europepmc.org/abstract/MED/21170298|Type: Wikipedia RefID: Drinabant URL: http://en.wikipedia.org/wiki/Drinabant";"Drinabant (INN)|";"";"";"";"";"";"CHEMBL3545166"
"CHEMBL1508";"ESCITALOPRAM";"Small molecule";"4";"2002";"";"CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(C#N)ccc21";"Serotonin transporter inhibitor";"reuptake inhibitor";"";"CHEMBL228";"Serotonin transporter";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=2db02476-325f-ee47-a7e5-b5aed56c364c#nlm34090-1 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2db02476-325f-ee47-a7e5-b5aed56c364c#nlm34090-1|Type: Wikipedia RefID: Escitalopram URL: http://en.wikipedia.org/wiki/Escitalopram";"Escitalopram (BAN, INN, MI)|Escitalopram Oxalate (FDA, JAN, MI, USAN, USP)|";"N06AB10";"N06AB - Selective serotonin reuptake inhibitors";"N06A - ANTIDEPRESSANTS";"N06 - PSYCHOANALEPTICS";"N - NERVOUS SYSTEM";"CHEMBL1508"
"CHEMBL3092650";"GSK239512";"Small molecule";"2";"None";"";"O=C1CCCN1c1ccc(Oc2ccc3c(c2)CCN(C2CCC2)CC3)nc1";"Histamine H3 receptor antagonist";"";"";"CHEMBL264";"Histamine H3 receptor";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 24269482 URL: http://europepmc.org/abstract/MED/24269482";"GSK239512";"";"";"";"";"";"CHEMBL3092650"
"CHEMBL372205";"LECOZOTAN";"Small molecule";"3";"None";"'-zotan'";"C[C@H](CN(C(=O)c1ccc(C#N)cc1)c1ccccn1)N1CCN(c2cccc3c2OCCO3)CC1";"Serotonin 1a (5-HT1a) receptor antagonist";"Not in current pipeline";"";"CHEMBL214";"Serotonin 1a (5-HT1a) receptor";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 15951399 URL: http://europepmc.org/abstract/MED/15951399";"Lecozotan HCl (USAN)|Lecozotan (INN)|";"";"";"";"";"";"CHEMBL372205"
"CHEMBL2104981";"RILAPLADIB";"Small molecule";"2";"None";"'-pladib'";"COCCN1CCC(N(Cc2ccc(-c3ccc(C(F)(F)F)cc3)cc2)C(=O)Cn2c(SCc3cccc(F)c3F)cc(=O)c3ccccc32)CC1";"LDL-associated phospholipase A2 inhibitor";"";"";"CHEMBL3514";"LDL-associated phospholipase A2";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 23973698 URL: http://europepmc.org/abstract/MED/23973698|Type: PubMed RefID: 24475026 URL: http://europepmc.org/abstract/MED/24475026";"Rilapladib (INN, USAN)|";"";"";"";"";"";"CHEMBL2104981"
"CHEMBL217092";"SARACATINIB";"Small molecule";"3";"None";"'-tinib'";"CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1";"Tyrosine-protein kinase SRC inhibitor";"";"";"CHEMBL267";"Tyrosine-protein kinase SRC";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 17064066 URL: http://europepmc.org/abstract/MED/17064066";"Saracatinib Difumarate (USAN)|Saracatinib (INN, USAN)|";"";"";"";"";"";"CHEMBL217092"
"CHEMBL119385";"NEFLAMAPIMOD";"Small molecule";"2";"None";"'-imod'";"O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl";"MAP kinase p38 alpha inhibitor";"";"";"CHEMBL260";"MAP kinase p38 alpha";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 24900264 URL: http://europepmc.org/abstract/MED/24900264";"Neflamapimod (USAN)|";"";"";"";"";"";"CHEMBL119385"
"CHEMBL2151197";"PF-03654746";"Small molecule";"2";"None";"";"CCNC(=O)[C@H]1C[C@@](F)(c2ccc(CN3CCCC3)c(F)c2)C1";"Histamine H3 receptor antagonist";"";"";"CHEMBL264";"Histamine H3 receptor";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 21928839 URL: http://europepmc.org/abstract/MED/21928839|Type: PubMed RefID: 22931528 URL: http://europepmc.org/abstract/MED/22931528";"PF-03654746";"";"";"";"";"";"CHEMBL2151197"
"CHEMBL635";"PREDNISONE";"Small molecule";"4";"1955";"'pred-'";"C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO";"Glucocorticoid receptor agonist";"";"";"CHEMBL2034";"Glucocorticoid receptor";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: ISBN RefID: 978-1-889788-85-2 URL: http://www.isbnsearch.org/isbn/9781889788852|Type: PubMed RefID: 22850902 URL: http://europepmc.org/abstract/MED/22850902|Type: Wikipedia RefID: Glucocorticoid URL: http://en.wikipedia.org/wiki/Glucocorticoid";"Prednisone (BAN, FDA, INN, MI, USP)|Prednisone tablets (USP)|";"H02AB07 | A07EA03";"H02AB - Glucocorticoids | A07EA - Corticosteroids acting locally";"H02A - CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN | A07E - INTESTINAL ANTIINFLAMMATORY AGENTS";"H02 - CORTICOSTEROIDS FOR SYSTEMIC USE | A07 - ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS";"H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS | A - ALIMENTARY TRACT AND METABOLISM";"CHEMBL635"
"CHEMBL217092";"SARACATINIB";"Small molecule";"3";"None";"'-tinib'";"CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1";"Tyrosine-protein kinase ABL inhibitor";"";"";"CHEMBL1862";"Tyrosine-protein kinase ABL";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 17064066 URL: http://europepmc.org/abstract/MED/17064066";"Saracatinib Difumarate (USAN)|Saracatinib (INN, USAN)|";"";"";"";"";"";"CHEMBL217092"
"CHEMBL621";"TRAZODONE";"Small molecule";"4";"1981";"";"O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12";"Serotonin 2a (5-HT2a) receptor antagonist";"";"";"CHEMBL224";"Serotonin 2a (5-HT2a) receptor";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: FDA RefID: label/2013/071258Orig1s040, 071196Orig1s063lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/071258Orig1s040, 071196Orig1s063lbl.pdf";"Trazodone HCl (FDA, JAN, MI, USAN, USP)|Trazodone (BAN, INN, MI)|";"N06AX05";"N06AX - Other antidepressants";"N06A - ANTIDEPRESSANTS";"N06 - PSYCHOANALEPTICS";"N - NERVOUS SYSTEM";"CHEMBL621"
"CHEMBL3306803";"LUMATEPERONE";"Small molecule";"3";"None";"'-perone'";"CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12";"Serotonin transporter inhibitor";"Atypical antipsychotic, shows partial agonism at the presynaptic D2 receptors and acts as an antagonist at postsynaptic D2 receptors (PMID: 25120104).";"";"CHEMBL228";"Serotonin transporter";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: Other RefID: http://www.intracellulartherapies.com/products-technology/iti-007.html URL: http://www.intracellulartherapies.com/products-technology/iti-007.html|Type: PubMed RefID: 24559051 URL: http://europepmc.org/abstract/MED/24559051|Type: PubMed RefID: 25120104 URL: http://europepmc.org/abstract/MED/25120104";"Lumateperone tosylate (USAN)|Lumateperone (USAN)|";"";"";"";"";"";"CHEMBL3306803"
"CHEMBL2105760";"BREXPIPRAZOLE";"Small molecule";"4";"2015";"'-prazole'";"O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1";"Serotonin 2a (5-HT2a) receptor antagonist";"";"";"CHEMBL224";"Serotonin 2a (5-HT2a) receptor";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: FDA RefID: label/2015/205422s000lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205422s000lbl.pdf";"Brexpiprazole (FDA, INN, JAN, USAN)|";"N05AX16";"N05AX - Other antipsychotics";"N05A - ANTIPSYCHOTICS";"N05 - PSYCHOLEPTICS";"N - NERVOUS SYSTEM";"CHEMBL2105760"
"CHEMBL457";"GEMFIBROZIL";"Small molecule";"4";"1981";"";"Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1";"Peroxisome proliferator-activated receptor alpha agonist";"";"";"CHEMBL239";"Peroxisome proliferator-activated receptor alpha";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=16a775ec-47e7-491f-8c48-319ce43dcd3b URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=16a775ec-47e7-491f-8c48-319ce43dcd3b|Type: Wikipedia RefID: Fibrates URL: http://en.wikipedia.org/wiki/Fibrates|Type: Wikipedia RefID: Gemfibrozil URL: http://en.wikipedia.org/wiki/Gemfibrozil";"Gemfibrozil (BAN, FDA, INN, JAN, MI, USAN, USP)|";"C10AB04";"C10AB - Fibrates";"C10A - LIPID MODIFYING AGENTS, PLAIN";"C10 - LIPID MODIFYING AGENTS";"C - CARDIOVASCULAR SYSTEM";"CHEMBL457"
"CHEMBL1378";"THIETHYLPERAZINE";"Small molecule";"4";"1961";"";"CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2";"Dopamine D2 receptor antagonist";"";"";"CHEMBL217";"Dopamine D2 receptor";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: ISBN RefID: 9780702034718 PP. 367 URL: http://www.isbnsearch.org/isbn/9780702034718|Type: PubMed RefID: 239403 URL: http://europepmc.org/abstract/MED/239403";"Thiethylperazine Maleate (FDA, USAN, USP)|Thietylperazine Maleate (JAN)|Thiethylperazine (BAN, INN, MI, USAN)|Thiethylperazine Malate (FDA, USP)|Thietylperazine Malate (JAN)|";"R06AD03";"R06AD - Phenothiazine derivatives";"R06A - ANTIHISTAMINES FOR SYSTEMIC USE";"R06 - ANTIHISTAMINES FOR SYSTEMIC USE";"R - RESPIRATORY SYSTEM";"CHEMBL1378"
"CHEMBL1464";"WARFARIN";"Small molecule";"4";"1954";"'-farin'";"CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O";"Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor";"";"";"CHEMBL1930";"Vitamin k epoxide reductase complex subunit 1 isoform 1";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=ba41b963-ec4a-4421-ac93-26654876a6be#nlm34090-1 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ba41b963-ec4a-4421-ac93-26654876a6be#nlm34090-1|Type: PubMed RefID: 14765195 URL: http://europepmc.org/abstract/MED/14765195";"Warfarin (BAN, INN, MI, USP)|Warfarin Potassium (FDA, JAN, MI, USP)|Warfarin sodium (FDA, USP)|Warfarin sodium salt (MI)|";"B01AA03";"B01AA - Vitamin K antagonists";"B01A - ANTITHROMBOTIC AGENTS";"B01 - ANTITHROMBOTIC AGENTS";"B - BLOOD AND BLOOD FORMING ORGANS";"CHEMBL1464"
"CHEMBL1373";"MODAFINIL";"Small molecule";"4";"1998";"";"NC(=O)C[S+]([O-])C(c1ccccc1)c1ccccc1";"Dopamine transporter inhibitor";"";"";"CHEMBL238";"Dopamine transporter";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=2c824d4c-2309-4e2a-bc74-aa8d80a5c454#nlm34090-1 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2c824d4c-2309-4e2a-bc74-aa8d80a5c454#nlm34090-1|Type: PubMed RefID: 11222668 URL: http://europepmc.org/abstract/MED/11222668";"Modafinil (BAN, FDA, INN, JAN, MI, USAN, USP)|Modafinil civ (USP)|";"N06BA07";"N06BA - Centrally acting sympathomimetics";"N06B - PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS";"N06 - PSYCHOANALEPTICS";"N - NERVOUS SYSTEM";"CHEMBL1373"
"CHEMBL4204869";"ELENBECESTAT";"Small molecule";"3";"None";"'-stat'";"C[C@H]1OC[C@]2(c3cc(NC(=O)c4cnc(C(F)F)cn4)ccc3F)N=C(N)SC[C@H]12";"Beta-secretase 1 inhibitor";"Orally bioavailable small molecule BACE1 inhibitor, has shown robust lowering of cerebral amyloid-beta in preclinical and clinical studies";"";"CHEMBL4822";"Beta-secretase 1";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 25621019 URL: http://europepmc.org/abstract/MED/25621019";"Elenbecestat (USAN)|";"";"";"";"";"";"CHEMBL4204869"
"CHEMBL1286";"LEVETIRACETAM";"Small molecule";"4";"1999";"'-racetam'";"CC[C@@H](C(N)=O)N1CCCC1=O";"Voltage-gated N-type calcium channel alpha-1B subunit blocker";"";"";"CHEMBL4478";"Voltage-gated N-type calcium channel alpha-1B subunit";"BLOCKER";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=90b553fe-4e94-4cce-b5df-ea3e6487930d#nlm34090-1 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=90b553fe-4e94-4cce-b5df-ea3e6487930d#nlm34090-1";"Levetiracetam (BAN, FDA, INN, JAN, MI, USAN, USP)|";"N03AX14";"N03AX - Other antiepileptics";"N03A - ANTIEPILEPTICS";"N03 - ANTIEPILEPTICS";"N - NERVOUS SYSTEM";"CHEMBL1286"
"CHEMBL1256786";"FORMOTEROL";"Small molecule";"4";"2001";"'-terol'";"COc1ccc(CC(C)NCC(O)c2ccc(O)c(NC=O)c2)cc1";"Beta-2 adrenergic receptor agonist";"Long acting";"";"CHEMBL210";"Beta-2 adrenergic receptor";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: FDA RefID: label/2016/022518s019,205641s005lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022518s019,205641s005lbl.pdf";"Formoterol Fumarate (FDA, JAN, MI, USAN, USP)|Formoterol fumarate (superceded) (USAN)|Formoterol Fumarate Dihydrate (FDA, MI)|Formoterol fumarate hydrate (JAN)|Formoterol (BAN, INN, MI)|";"R03AC13";"R03AC - Selective beta-2-adrenoreceptor agonists";"R03A - ADRENERGICS, INHALANTS";"R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES";"R - RESPIRATORY SYSTEM";"CHEMBL1256786"
"CHEMBL54";"HALOPERIDOL";"Small molecule";"4";"1967";"'-peridol'";"O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1";"Serotonin 2a (5-HT2a) receptor antagonist";"";"";"CHEMBL224";"Serotonin 2a (5-HT2a) receptor";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: ISBN RefID: 0443059748 URL: http://www.isbnsearch.org/isbn/0443059748|Type: PubMed RefID: 17015232 URL: http://europepmc.org/abstract/MED/17015232|Type: Wikipedia RefID: Haloperidol URL: http://en.wikipedia.org/wiki/Haloperidol";"Haloperidol (BAN, FDA, INN, JAN, MI, USAN, USP)|Haloperidol Lactate (FDA)|";"N05AD01";"N05AD - Butyrophenone derivatives";"N05A - ANTIPSYCHOTICS";"N05 - PSYCHOLEPTICS";"N - NERVOUS SYSTEM";"CHEMBL54"
"CHEMBL1487";"ATORVASTATIN";"Small molecule";"4";"1996";"'-stat-'";"CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O";"HMG-CoA reductase inhibitor";"";"";"CHEMBL402";"HMG-CoA reductase";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=6ccdb6f3-22c7-5b48-46bc-ce4a4c65eb4d#section-13 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6ccdb6f3-22c7-5b48-46bc-ce4a4c65eb4d#section-13";"Atorvastatin (BAN, INN, MI)|Atorvastatin Calcium (FDA, USAN, USP)|Atorvastatin calcium hydrate (JAN)|Atorvastatin calcium salt anhydrous (MI)|Atorvastatin calcium salt trihydrate (MI)|";"C10AA05";"C10AA - HMG CoA reductase inhibitors";"C10A - LIPID MODIFYING AGENTS, PLAIN";"C10 - LIPID MODIFYING AGENTS";"C - CARDIOVASCULAR SYSTEM";"CHEMBL1487"
"CHEMBL1017";"TELMISARTAN";"Small molecule";"4";"1998";"'-sartan'";"CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1";"Type-1 angiotensin II receptor antagonist";"";"";"CHEMBL227";"Type-1 angiotensin II receptor";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=cfb9309f-e0df-4a55-9542-0e869fce05fb#section-14 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cfb9309f-e0df-4a55-9542-0e869fce05fb#section-14|Type: PubMed RefID: 16938288 URL: http://europepmc.org/abstract/MED/16938288|Type: PubMed RefID: 18580862 URL: http://europepmc.org/abstract/MED/18580862|Type: Wikipedia RefID: Telmisartan URL: http://en.wikipedia.org/wiki/Telmisartan";"Telmisartan (BAN, FDA, INN, JAN, MI, USAN, USP)|";"C09CA07";"C09CA - Angiotensin II receptor blockers (ARBs), plain";"C09C - ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN";"C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM";"C - CARDIOVASCULAR SYSTEM";"CHEMBL1017"
"CHEMBL637";"VENLAFAXINE";"Small molecule";"4";"1993";"'-faxine'";"COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1";"Serotonin transporter inhibitor";"";"";"CHEMBL228";"Serotonin transporter";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=f2f03495-12b6-457a-901f-958b9c844bfd#nlm34090-1 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f2f03495-12b6-457a-901f-958b9c844bfd#nlm34090-1";"Venlafaxine (BAN, INN, MI)|Venlafaxine HCl (FDA, JAN, MI, USAN, USP)|";"N06AX16";"N06AX - Other antidepressants";"N06A - ANTIDEPRESSANTS";"N06 - PSYCHOANALEPTICS";"N - NERVOUS SYSTEM";"CHEMBL637"
"CHEMBL2087337";"VELUSETRAG";"Small molecule";"2";"None";"'-setrag'";"CC(C)n1c(=O)c(C(=O)N[C@@H]2C[C@@H]3CC[C@H](C2)N3C[C@@H](O)CN(C)S(C)(=O)=O)cc2ccccc21";"Serotonin 4 (5-HT4) receptor agonist";"";"";"CHEMBL1875";"Serotonin 4 (5-HT4) receptor";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 18415081 URL: http://europepmc.org/abstract/MED/18415081";"Velusetrag HCl (USAN)|Velusetrag (INN, USAN)|";"";"";"";"";"";"CHEMBL2087337"
"CHEMBL3545029";"ABT-288";"Small molecule";"2";"None";"";"CN1CC2CCN(c3ccc(-c4ccc(-n5ncccc5=O)cc4)cc3)C2C1";"Histamine H3 receptor antagonist";"";"";"CHEMBL264";"Histamine H3 receptor";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 20864505 URL: http://europepmc.org/abstract/MED/20864505";"ABT-288";"";"";"";"";"";"CHEMBL3545029"
"CHEMBL1112";"ARIPIPRAZOLE";"Small molecule";"4";"2002";"'-prazole'";"O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1";"Serotonin 2a (5-HT2a) receptor antagonist";"";"";"CHEMBL224";"Serotonin 2a (5-HT2a) receptor";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=c040bd1d-45b7-49f2-93ea-aed7220b30ac#nlm34090-1 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c040bd1d-45b7-49f2-93ea-aed7220b30ac#nlm34090-1";"Aripiprazole (BAN, FDA, INN, JAN, MI, USAN, USP)|";"N05AX12";"N05AX - Other antipsychotics";"N05A - ANTIPSYCHOTICS";"N05 - PSYCHOLEPTICS";"N - NERVOUS SYSTEM";"CHEMBL1112"
"CHEMBL1433";"DOXYCYCLINE";"Small molecule";"4";"1967";"'-cycline'";"C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21";"Matrix metalloproteinase-1 inhibitor";"It is an antibiotic, however, its primary action, due to the concentration reached in the human body is via metalloproteinases inhibition, which is beneficial in many pathological conditions in which MMP-mediated proteolysis of the extracellular matrix (ECM) contributes to the pathogenesis, such as heart remodeling, tumor invasion, and inflammation";"";"CHEMBL332";"Matrix metalloproteinase-1";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=3105a84b-655e-4940-9d11-4209cdb05d6b URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3105a84b-655e-4940-9d11-4209cdb05d6b|Type: PubMed RefID: 17199549 URL: http://europepmc.org/abstract/MED/17199549|Type: PubMed RefID: 20370419 URL: http://europepmc.org/abstract/MED/20370419|Type: PubMed RefID: 20592239 URL: http://europepmc.org/abstract/MED/20592239";"Doxycycline Calcium (FDA, USP)|Doxycycline (BAN, FDA, INN, USAN, USP, BAN, USAN, USP)|Doxycycline anhydrous (MI)|Doxycycline HCl (JAN)|Doxycycline Fosfatex (BAN, USAN)|Doxycycline hyclate (FDA, USP)|Doxycycline hydrochloride hydrate (JAN)|";"A01AB22 | J01AA02";"A01AB - Antiinfectives and antiseptics for local oral treatment | J01AA - Tetracyclines";"A01A - STOMATOLOGICAL PREPARATIONS | J01A - TETRACYCLINES";"A01 - STOMATOLOGICAL PREPARATIONS | J01 - ANTIBACTERIALS FOR SYSTEMIC USE";"A - ALIMENTARY TRACT AND METABOLISM | J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL1433"
"CHEMBL3286580";"IDALOPIRDINE";"Small molecule";"3";"None";"'-pirdine'";"Fc1ccc2c(CCNCc3cccc(OCC(F)(F)C(F)F)c3)c[nH]c2c1";"Serotonin 6 (5-HT6) receptor antagonist";"";"";"CHEMBL3371";"Serotonin 6 (5-HT6) receptor";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: Other RefID: http://investor.lundbeck.com/pipeline.cfm URL: http://investor.lundbeck.com/pipeline.cfm|Type: PubMed RefID: 25297016 URL: http://europepmc.org/abstract/MED/25297016";"Idalopirdine (INN, USAN)|";"";"";"";"";"";"CHEMBL3286580"
"CHEMBL1201774";"SAPROPTERIN";"Small molecule";"4";"2007";"";"C[C@H](O)[C@H](O)[C@H]1CNc2nc(N)nc(O)c2N1";"Phenylalanine-4-hydroxylase activator";"";"";"CHEMBL3076";"Phenylalanine-4-hydroxylase";"ACTIVATOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=af38711e-8873-4790-a92d-4d583e23fb89#nlm34090-1 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=af38711e-8873-4790-a92d-4d583e23fb89#nlm34090-1";"Sapropterin dihydrochloride (FDA, MI, USAN)|Sapropterin hydrochloride (JAN)|Sapropterin (INN, MI)|";"A16AX07";"A16AX - Various alimentary tract and metabolism products";"A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS";"A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS";"A - ALIMENTARY TRACT AND METABOLISM";"CHEMBL1201774"
"CHEMBL103";"PROGESTERONE";"Small molecule";"4";"1976";"'-gest-; -ster-'";"CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C";"Progesterone receptor agonist";"";"";"CHEMBL208";"Progesterone receptor";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 10997774 URL: http://europepmc.org/abstract/MED/10997774";"Progesterone (BAN, FDA, INN, JAN, MI, USP)|";"G03DA04";"G03DA - Pregnen (4) derivatives";"G03D - PROGESTOGENS";"G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM";"G - GENITO URINARY SYSTEM AND SEX HORMONES";"CHEMBL103"
"CHEMBL2111101";"PIMAVANSERIN";"Small molecule";"4";"2016";"'-anserin'";"CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1";"Serotonin 2a (5-HT2a) receptor inverse agonist";"";"";"CHEMBL224";"Serotonin 2a (5-HT2a) receptor";"INVERSE AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: Other RefID: http://www.acadia-pharm.com/pipeline/nuplazid-pdp/ URL: http://www.acadia-pharm.com/pipeline/nuplazid-pdp/|Type: PubMed RefID: 16469866 URL: http://europepmc.org/abstract/MED/16469866|Type: PubMed RefID: 7806373 URL: http://europepmc.org/abstract/MED/7806373|Type: Wikipedia RefID: Pimavanserin URL: http://en.wikipedia.org/wiki/Pimavanserin";"Pimavanserin (INN)|Pimavanserin tartrate (FDA)|Pimavanserin Tartrate (USAN)|";"N05AX17";"N05AX - Other antipsychotics";"N05A - ANTIPSYCHOTICS";"N05 - PSYCHOLEPTICS";"N - NERVOUS SYSTEM";"CHEMBL2111101"
"CHEMBL559478";"SSR180711";"Small molecule";"2";"None";"";"O=C(Oc1ccc(Br)cc1)N1CCN2CCC1CC2";"Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist";"";"";"CHEMBL2492";"Neuronal acetylcholine receptor protein alpha-7 subunit";"PARTIAL AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 17019409 URL: http://europepmc.org/abstract/MED/17019409|Type: PubMed RefID: 21919481 URL: http://europepmc.org/abstract/MED/21919481";"SSR-180711";"";"";"";"";"";"CHEMBL559478"
"CHEMBL218166";"BIFEPRUNOX";"Small molecule";"3";"None";"";"O=c1[nH]c2cccc(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)c2o1";"Serotonin 1a (5-HT1a) receptor partial agonist";"";"High affinity: D3 and D4 receptors. Low affinity: a1, 5HT2A, 5HT2C, H1 and muscarinic receptors ";"CHEMBL214";"Serotonin 1a (5-HT1a) receptor";"PARTIAL AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 18597078 URL: http://europepmc.org/abstract/MED/18597078";"Bifeprunox (INN, MI, USAN)|Bifeprunox Mesylate (USAN)|";"";"";"";"";"";"CHEMBL218166"
"CHEMBL81";"RALOXIFENE";"Small molecule";"4";"1997";"'-ifene'";"O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12";"Estrogen receptor beta modulator";"Mixed agonist/antagonist";"";"CHEMBL242";"Estrogen receptor beta";"MODULATOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=fcaaa6dc-74e8-4fb8-800c-5574bf0f8de9#nlm34090-1 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fcaaa6dc-74e8-4fb8-800c-5574bf0f8de9#nlm34090-1|Type: Wikipedia RefID: Estrogen_receptor URL: http://en.wikipedia.org/wiki/Estrogen_receptor";"Raloxifene (BAN, INN, MI)|Raloxifene HCl (FDA, JAN, MI, USAN, USP)|";"G03XC01";"G03XC - Selective estrogen receptor modulators";"G03X - OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM";"G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM";"G - GENITO URINARY SYSTEM AND SEX HORMONES";"CHEMBL81"
"CHEMBL1083390";"INTEPIRDINE";"Small molecule";"3";"None";"'-pirdine'";"O=S(=O)(c1ccccc1)c1cnc2c(N3CCNCC3)cccc2c1";"Serotonin 6 (5-HT6) receptor antagonist";"";"";"CHEMBL3371";"Serotonin 6 (5-HT6) receptor";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 18625457 URL: http://europepmc.org/abstract/MED/18625457";"Intepirdine (INN, USAN)|";"";"";"";"";"";"CHEMBL1083390"
"CHEMBL1276308";"MIFEPRISTONE";"Small molecule";"4";"2000";"'-pristone'";"CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C";"Glucocorticoid receptor antagonist";"";"Selective";"CHEMBL2034";"Glucocorticoid receptor";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=542f3fae-8bc8-4f00-9228-e4b66c9ad6a9 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=542f3fae-8bc8-4f00-9228-e4b66c9ad6a9|Type: PubMed RefID: 22466348 URL: http://europepmc.org/abstract/MED/22466348";"Mifepristone (BAN, FDA, INN, JAN, MI, USAN, USP)|";"G03XB51 | G03XB01";"G03XB - Progesterone receptor modulators | G03XB - Progesterone receptor modulators";"G03X - OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM | G03X - OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM";"G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM | G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM";"G - GENITO URINARY SYSTEM AND SEX HORMONES | G - GENITO URINARY SYSTEM AND SEX HORMONES";"CHEMBL1276308"
"CHEMBL1421";"DASATINIB";"Small molecule";"4";"2006";"'-tinib'";"Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1";"Ephrin type-A receptor 2 inhibitor";"";"";"CHEMBL2068";"Ephrin type-A receptor 2";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13";"Dasatinib (FDA, INN, MI, USAN)|Dasatinib hydrate (JAN)|";"L01XE06";"L01XE - Protein kinase inhibitors";"L01X - OTHER ANTINEOPLASTIC AGENTS";"L01 - ANTINEOPLASTIC AGENTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL1421"
